ID

38681

Description

Study ID: 113222 Clinical Study ID: 113222 Study Title: A Phase II, Open Label, Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00920556 Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name:5.0g SRT501 Trade Name: Bortezomib Study Indication: Multiple Myeloma

Keywords

Versions (4)
  1. 3/4/19 3/4/19 -
  2. 3/10/19 3/10/19 -
  3. 3/10/19 3/10/19 -
  4. 10/30/19 10/30/19 - Sarah Riepenhausen
Copyright Holder

GlaxoSmithKline

Uploaded on

October 30, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Safety and Activity of SRT501 Alone or in Combination with Bortezomib in Patients with Multiple Myeloma NCT00920556

English

Non Visit - Adverse Events; Prior and Concomitant Medications; Comments; Protocol Deviations; Data Verification

1 forms  
Administrative
Description

Administrative

Alias
UMLS CUI-1
C1320722
Subject Number
Description

Subject Number

Data type

integer

Alias
UMLS CUI [1]
C2348585
Adverse Events
Description

Adverse Events

Alias
UMLS CUI-1
C0877248
Has the Subject experienced any new Adverse Events occurring after signing the Informed Consent?
Description

If Yes, please record details below

Data type

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0205314
UMLS CUI [2]
C0021430
Adverse Events
Description

Adverse Events

Alias
UMLS CUI-1
C0877248
Seq #
Description

Seq #

Data type

integer

Alias
UMLS CUI [1]
C0237753
Adverse Event
Description

Please enter one event per line.

Data type

text

Alias
UMLS CUI [1]
C0877248
Start date and time of Adverse Event
Description

Start date and time of Adverse Event

Data type

datetime

Alias
UMLS CUI [1]
C2826806
End date and time of Adverse Event
Description

End date and time of Adverse Event

Data type

datetime

Alias
UMLS CUI [1]
C2826793
Intensity of Adverse Event
Description

Enter only one.

Data type

integer

Frequency of Adverse Event
Description

Frequency of Adverse Event

Data type

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0439603
Relationship to SRT501
Description

Enter only one

Data type

integer

Alias
UMLS CUI [1,1]
C0304229
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0877248
Relationship to bortezomib
Description

Relationship to bortezomib

Data type

text

Alias
UMLS CUI [1,1]
C1176309
UMLS CUI [1,2]
C0439849
UMLS CUI [1,3]
C0877248
Action Taken with SRT501
Description

Enter only one.

Data type

integer

Alias
UMLS CUI [1]
C2826626
Other Action taken
Description

If Other, please specify.

Data type

integer

Alias
UMLS CUI [1,1]
C2826626
UMLS CUI [1,2]
C0205394
Action Taken with bortezomib
Description

Enter only one.

Data type

integer

Alias
UMLS CUI [1,1]
C2826626
UMLS CUI [1,2]
C1176309
Outcome
Description

Enter only one.

Data type

integer

Alias
UMLS CUI [1]
C1705586
SAE?
Description

SAE?

Data type

boolean

Alias
UMLS CUI [1]
C1519255
Prior and Concomitant Medications
Description

Prior and Concomitant Medications

Alias
UMLS CUI-1
C2826257
UMLS CUI-2
C2347852
Has the Subject had any treatment (medication, device or therapy) within 28 days prior to first dose of SRT501 or during the study period?
Description

If Yes, please record details below.

Data type

boolean

Alias
UMLS CUI [1,1]
C2826257
UMLS CUI [1,2]
C2347852
Prior and Concomitant Medications
Description

Prior and Concomitant Medications

Alias
UMLS CUI-1
C2826257
UMLS CUI-2
C2347852
Seq #
Description

Seq #

Data type

integer

Alias
UMLS CUI [1]
C0237753
Medication, device or therapy
Description

e.g. PARACETAMOL

Data type

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C1504335
Start date
Description

Start date

Data type

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0808070
End date
Description

End date

Data type

date

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0806020
Dose
Description

e.g. 500

Data type

integer

Alias
UMLS CUI [1]
C3174092
Unit
Description

e.g. mg

Data type

text

Alias
UMLS CUI [1]
C1519795
Route
Description

e.g. PO

Data type

text

Alias
UMLS CUI [1]
C0013153
Frequency
Description

e.g. BD

Data type

text

Alias
UMLS CUI [1]
C3476109
Indication
Description

e.g. headache

Data type

text

Alias
UMLS CUI [1]
C3146298
If indication is an adverse event, please record sequence number(s) from the AE page
Description

e.g. 02

Data type

integer

Alias
UMLS CUI [1,1]
C3146298
UMLS CUI [1,2]
C0877248
UMLS CUI [2]
C2348184
Are any comments required?
Description

Are any comments required?

Alias
UMLS CUI-1
C0947611
UMLS CUI-2
C1514873
Are any comments required?
Description

If Yes, please record details below

Data type

boolean

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C1514873
Comments
Description

Comments

Alias
UMLS CUI-1
C0947611
Seq #
Description

Seq #

Data type

integer

Alias
UMLS CUI [1]
C0237753
CRF Page referenced
Description

CRF Page referenced

Data type

text

Alias
UMLS CUI [1,1]
C1704732
UMLS CUI [1,2]
C1516308
Comment
Description

Comment

Data type

text

Alias
UMLS CUI [1]
C0947611
Did the subject deviate from the procedures as described in the protocol?
Description

Did the subject deviate from the procedures as described in the protocol?

Alias
UMLS CUI-1
C1705236
Did the subject deviate from the procedures as described in the protocol?
Description

If Yes, please record details below

Data type

boolean

Alias
UMLS CUI [1]
C1705236
Protocol Deviations
Description

Protocol Deviations

Alias
UMLS CUI-1
C1705236
Seq #
Description

Seq #

Data type

integer

Alias
UMLS CUI [1]
C0237753
CRF Page referenced
Description

CRF Page referenced

Data type

text

Alias
UMLS CUI [1,1]
C1704732
UMLS CUI [1,2]
C1516308
Code
Description

Code

Data type

integer

Data Verification
Description

Data Verification

Alias
UMLS CUI-1
C4086865
Investigator's Signuature
Description

Investigator statement - I confirm that to the best of my knowledge, the observations and data are recorded completely and accurately within this CRF.

Data type

text

Alias
UMLS CUI [1]
C4086865
UMLS CUI [2]
C2346576
Signature Date
Description

Signature Date

Data type

date

Alias
UMLS CUI [1,1]
C2346576
UMLS CUI [1,2]
C0011008
Back to the top of the page

Similar models

Non Visit - Adverse Events; Prior and Concomitant Medications; Comments; Protocol Deviations; Data Verification

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Subject Number
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
Adverse Events
C0877248 (UMLS CUI-1)
Has the Subject experienced any new Adverse Events occurring after signing the Informed Consent?
Item
Has the Subject experienced any new Adverse Events occurring after signing the Informed Consent?
boolean
C0877248 (UMLS CUI [1,1])
C0205314 (UMLS CUI [1,2])
C0021430 (UMLS CUI [2])
Item Group
Adverse Events
C0877248 (UMLS CUI-1)
Seq #
Item
Seq #
integer
C0237753 (UMLS CUI [1])
Adverse Event
Item
Adverse Event
text
C0877248 (UMLS CUI [1])
Start date and time of Adverse Event
Item
Start date and time of Adverse Event
datetime
C2826806 (UMLS CUI [1])
End date and time of Adverse Event
Item
End date and time of Adverse Event
datetime
C2826793 (UMLS CUI [1])
Item
Intensity of Adverse Event
integer
Intensity of Adverse Event
Code List
Intensity of Adverse Event
CL Item
Mild  (1)
CL Item
Moderate  (2)
CL Item
Severe  (3)
CL Item
Life threatening or Disabling (4)
CL Item
Death (5)
Item
Frequency of Adverse Event
integer
C0877248 (UMLS CUI [1,1])
C0439603 (UMLS CUI [1,2])
Frequency of Adverse Event
Code List
Frequency of Adverse Event
CL Item
Intermittent  (1)
CL Item
Continuous (2)
Item
Relationship to SRT501
integer
C0304229 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
Relationship to SRT501
Code List
Relationship to SRT501
CL Item
Not related  (0)
CL Item
Unlikely related  (1)
CL Item
Possibly related  (2)
CL Item
Probably related  (3)
CL Item
Definitely related (4)
Relationship to bortezomib
Item
Relationship to bortezomib
text
C1176309 (UMLS CUI [1,1])
C0439849 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
Item
Action Taken with SRT501
integer
C2826626 (UMLS CUI [1])
Action Taken with SRT501
Code List
Action Taken with SRT501
CL Item
None  (0)
CL Item
Drug Withdrawn  (1)
CL Item
Dose reduced  (2)
CL Item
Dose increased  (3)
CL Item
Dose not changed (4)
CL Item
Unknown  (97)
CL Item
Not Applicable (98)
Item
Other Action taken
integer
C2826626 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Other Action taken
Code List
Other Action taken
CL Item
None  (1)
CL Item
Concomitant Medication  (2)
CL Item
Other (99)
Item
Action Taken with bortezomib
integer
C2826626 (UMLS CUI [1,1])
C1176309 (UMLS CUI [1,2])
Action Taken with bortezomib
Code List
Action Taken with bortezomib
CL Item
None  (0)
CL Item
Drug Withdrawn  (1)
CL Item
Dose reduced  (2)
CL Item
Dose increased  (3)
CL Item
Dose not changed  (4)
CL Item
Unknown  (97)
CL Item
Not Applicable (98)
Item
Outcome
integer
C1705586 (UMLS CUI [1])
Outcome
Code List
Outcome
CL Item
Resolved without sequalae (1)
CL Item
Resolved with sequalae  (2)
CL Item
Not yet resolved  (3)
CL Item
Death  (4)
CL Item
Unknown (97)
SAE?
Item
SAE?
boolean
C1519255 (UMLS CUI [1])
Item Group
Prior and Concomitant Medications
C2826257 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Has the Subject had any treatment (medication, device or therapy) within 28 days prior to first dose of SRT501 or during the study period?
Item
Has the Subject had any treatment (medication, device or therapy) within 28 days prior to first dose of SRT501 or during the study period?
boolean
C2826257 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item Group
Prior and Concomitant Medications
C2826257 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Seq #
Item
Seq #
integer
C0237753 (UMLS CUI [1])
Medication, device or therapy
Item
Medication, device or therapy
text
C0013227 (UMLS CUI [1,1])
C1504335 (UMLS CUI [1,2])
Start date
Item
Start date
date
C0013227 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
End date
Item
End date
date
C0013227 (UMLS CUI [1,1])
C0806020 (UMLS CUI [1,2])
Dose
Item
Dose
integer
C3174092 (UMLS CUI [1])
Item
Unit
text
C1519795 (UMLS CUI [1])
Unit
Code List
Unit
CL Item
AMPOULES  (AMP)
CL Item
APPLICATION  (APP)
CL Item
CAPSULES  (CAP)
CL Item
CENTIMETRES  (CM)
CL Item
CUBIC CENTIMETRES  (CC)
CL Item
DEGREES CENTIGRADE  (C)
CL Item
DEGREES FAHRENHEIT  (F)
CL Item
DROP(S)  (GT)
CL Item
GRAIN(S)  (GRN)
CL Item
GRAMS  (G)
CL Item
INCHES  (IN)
CL Item
INHALATION  (INH)
CL Item
INTERNATIONAL UNITS  (IU)
CL Item
KILOGRAMS  (KG)
CL Item
LITRES  (L)
CL Item
LOZENGES  (LOZ)
CL Item
METRES  (M)
CL Item
MILLIEQUIVALENTS  (ME)
CL Item
MILLIGRAMS  (MG)
CL Item
MILLILITRES  (ML)
CL Item
MILLIMETRES  (MM)
CL Item
MILLIMOLES  (MMOL)
CL Item
MICROGRAMS  (MCG)
CL Item
MICROGRAMS/KILOGRAM  (MCG/KG)
CL Item
MICROLITRES  (UL)
CL Item
NANOGRAMS  (NG)
CL Item
NOT KNOWN  (NK)
CL Item
OTHER  (OTH)
CL Item
PERCENTAGE  (%)
CL Item
PESSARIES  (PES)
CL Item
POUNDS  (LB)
CL Item
PUFFS  (PFF)
CL Item
SACHETS  (SAC)
CL Item
SPRAY  (SPR)
CL Item
SUPPOSITORIES  (SUP)
CL Item
TABLESPOONS  (TBSP)
CL Item
TABLETS  (TAB)
CL Item
TEASPOONS  (TSP)
CL Item
VIALS (VI)
Item
Route
text
C0013153 (UMLS CUI [1])
Route
Code List
Route
CL Item
AURAL  (AU)
CL Item
DUODENAL TUBE  (DUT)
CL Item
EPIDURAL  (EPD)
CL Item
INHALED  (IH)
CL Item
INTRA-ARTERIAL  (IAR)
CL Item
INTRA-ARTICULAR INJECTION  (IA)
CL Item
INTRADERMAL  (ID)
CL Item
INTRALESIONAL  (IL)
CL Item
INTRAMUSCULAR  (IM)
CL Item
INTRATHECAL  (IT)
CL Item
INTRAVENOUS  (IV)
CL Item
INTRAVENOUS DIRECT  (IVD)
CL Item
INTRAVENOUS INDWELLING  (IVI)
CL Item
INTRAVENOUS PUSH  (IVP)
CL Item
NASAL  (NA)
CL Item
NASOGASTRIC  (NGA)
CL Item
NOT KNOWN  (NK)
CL Item
OPHTHALMIC  (OPT)
CL Item
ORAL  (PO)
CL Item
OTHER  (OTH)
CL Item
RECTAL  (PR)
CL Item
SUBCUTANEOUS  (SC)
CL Item
SUBLINGUAL  (SL)
CL Item
TRANSDERMAL  (TD)
CL Item
TOPICAL  (TOP)
CL Item
VAGINAL (VA)
Item
Frequency
text
C3476109 (UMLS CUI [1])
Frequency
Code List
Frequency
CL Item
AS NEEDED  (PRN)
CL Item
CONTINUOUS  (CONT)
CL Item
EVERY HOUR  (Q1H)
CL Item
EVERY NIGHT/NOCTE  (ON)
CL Item
EVERY OTHER DAY  (QOD)
CL Item
EVERY 2 HOURS  (Q2H)
CL Item
EVERY 3 HOURS  (Q3H)
CL Item
EVERY 4 HOURS  (Q4H)
CL Item
EVERY 6 HOURS  (Q6H)
CL Item
EVERY 8 HOURS  (Q8H)
CL Item
EVERY 12 HOURS  (Q12H)
CL Item
EVERY OTHER WEEK  (Q14D)
CL Item
EVERY 28 DAYS  (Q28D)
CL Item
IN THE MORNING/MANE  (OM)
CL Item
MONTHLY  (MON)
CL Item
NOT KNOWN  (NK)
CL Item
ONCE/SINGLE DOSE  (X1)
CL Item
ONCE PER DAY  (QD)
CL Item
ONCE PER WEEK  (QWK)
CL Item
OTHER  (OTH)
CL Item
TWICE PER WEEK  (BWK)
CL Item
TWICE PER DAY  (BD)
CL Item
THREE TIMES PER DAY  (TDS)
CL Item
FOUR TIMES PER DAY  (QDS)
CL Item
WITH MEALS (WM)
Indication
Item
Indication
text
C3146298 (UMLS CUI [1])
If indication is an adverse event, please record sequence number(s) from the AE page
Item
If indication is an adverse event, please record sequence number(s) from the AE page
integer
C3146298 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
C2348184 (UMLS CUI [2])
Item Group
Are any comments required?
C0947611 (UMLS CUI-1)
C1514873 (UMLS CUI-2)
Are any comments required?
Item
Are any comments required?
boolean
C0947611 (UMLS CUI [1,1])
C1514873 (UMLS CUI [1,2])
Item Group
Comments
C0947611 (UMLS CUI-1)
Seq #
Item
Seq #
integer
C0237753 (UMLS CUI [1])
CRF Page referenced
Item
CRF Page referenced
text
C1704732 (UMLS CUI [1,1])
C1516308 (UMLS CUI [1,2])
Comment
Item
Comment
text
C0947611 (UMLS CUI [1])
Item Group
Did the subject deviate from the procedures as described in the protocol?
C1705236 (UMLS CUI-1)
Did the subject deviate from the procedures as described in the protocol?
Item
Did the subject deviate from the procedures as described in the protocol?
boolean
C1705236 (UMLS CUI [1])
Item Group
Protocol Deviations
C1705236 (UMLS CUI-1)
Seq #
Item
Seq #
integer
C0237753 (UMLS CUI [1])
CRF Page referenced
Item
CRF Page referenced
text
C1704732 (UMLS CUI [1,1])
C1516308 (UMLS CUI [1,2])
Item
Code
integer
Code
Code List
Code
CL Item
Unmet Inclusion Criteria/Exclusion Criteria (please specify the IC/EC number)  (1)
CL Item
Consent signed after study procedures started  (2)
CL Item
Visit not done (please specify visit)  (3)
CL Item
Visit out of window (please specify visit)  (4)
CL Item
Procedure out of allowable or permissible time label (please specify procedure)  (5)
CL Item
Dosing not performed according to the protocol  (6)
CL Item
Sampling not performed according to the protocol  (7)
CL Item
Meal not consumed according to the protocol  (8)
CL Item
Subject ingested large quantities of resveratrol containing food and drink such as peanuts, grapes, mulberries and alcohol within 48 hours prior to PK sample collections. (Only applicable for PK subjects). (9)
CL Item
Other (please specify) (10)
CL Item
Other (please specify) (10)
Item Group
Data Verification
C4086865 (UMLS CUI-1)
Investigator statement
Item
Investigator's Signuature
text
C4086865 (UMLS CUI [1])
C2346576 (UMLS CUI [2])
Signature Date
Item
Signature Date
date
C2346576 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial